Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR.
Sun Y, Gao Y, Dong M, Li J, Li X, He N, Song H, Zhang M, Ji K, Wang J, et al. J Exp Clin Cancer Res. 2023 Jun 3; 42(1):140. Epub 2023 Jun 3.